But an association with improved overall survival failed to reach statistical significance ...

Oxybutynin, a common drug to manage overactive bladder, may help alleviate hot flash symptoms among men receiving androgen ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.

“Oxybutynin demonstrated clear and clinically meaningful improvements in both hot flash frequency and quality of life for men undergoing hormone therapy for prostate cancer,” said lead researcher Dr.

Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...